GlaxoSmithKline Pharmaceuticals Limited Cash Flow Quality Index
GlaxoSmithKline Pharmaceuticals Limited cash flow quality index. GlaxoSmithKline Pharmaceuticals Limited (GLAXO) has a Cash Flow Quality Index of 0.75x as of December 2023. Operating cash flow of Rs342.20 Million is below net income of Rs457.20 Million, suggesting accrual-heavy earnings not yet converted to cash. See GlaxoSmithKline Pharmaceuticals Limited leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of GlaxoSmithKline Pharmaceuticals Limited (2005–2025)
Cash flow quality index of GlaxoSmithKline Pharmaceuticals Limited from 2005 to 2025. Historical Cash Flow Quality Index for GlaxoSmithKline Pharmaceuticals Limited across 21 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore cash flow to debt ratio of GlaxoSmithKline Pharmaceuticals Limited to assess how comfortably operating cash covers total debt obligations.
GlaxoSmithKline Pharmaceuticals Limited Cash Flow Quality Index by Year (2005–2025)
GlaxoSmithKline Pharmaceuticals Limited cash flow quality index by year from 2005 to 2025. Year-by-year earnings quality comparison for GlaxoSmithKline Pharmaceuticals Limited. For the full cash flow conversion analysis, see GLAXO cash flow conversion.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.39x | Rs12.90 Billion | Rs9.28 Billion | ▲ +41.0% |
| 2024 | 0.99x | Rs5.82 Billion | Rs5.90 Billion | ▲ +71.4% |
| 2023 | 0.58x | Rs4.84 Billion | Rs8.41 Billion | ▲ +75.7% |
| 2022 | 0.33x | Rs8.11 Billion | Rs24.76 Billion | ▼ -59.0% |
| 2021 | 0.80x | Rs5.78 Billion | Rs7.23 Billion | ▲ +5.5% |
| 2020 | 0.76x | Rs4.90 Billion | Rs6.47 Billion | ▲ +24.1% |
| 2019 | 0.61x | Rs3.99 Billion | Rs6.54 Billion | ▼ -32.6% |
| 2018 | 0.91x | Rs4.73 Billion | Rs5.22 Billion | ▲ +78.6% |
| 2017 | 0.51x | Rs2.36 Billion | Rs4.65 Billion | ▲ +110.1% |
| 2016 | 0.24x | Rs1.39 Billion | Rs5.77 Billion | ▼ -66.0% |
| 2015 | 0.71x | Rs2.70 Billion | Rs3.81 Billion | ▲ +72.6% |
| 2014 | 0.41x | Rs2.81 Billion | Rs6.85 Billion | ▲ +28.6% |
| 2013 | 0.32x | Rs3.14 Billion | Rs9.83 Billion | ▼ -11.8% |
| 2012 | 0.36x | Rs3.36 Billion | Rs9.27 Billion | ▼ -34.2% |
| 2011 | 0.55x | Rs4.79 Billion | Rs8.72 Billion | ▼ -18.2% |
| 2010 | 0.67x | Rs5.12 Billion | Rs7.61 Billion | ▲ +42.7% |
| 2009 | 0.47x | Rs3.30 Billion | Rs7.01 Billion | ▼ -7.3% |
| 2008 | 0.51x | Rs3.19 Billion | Rs6.28 Billion | ▲ +11.3% |
| 2007 | 0.46x | Rs2.59 Billion | Rs5.66 Billion | ▼ -36.2% |
| 2006 | 0.72x | Rs3.49 Billion | Rs4.88 Billion | ▲ +33.6% |
| 2005 | 0.54x | Rs2.29 Billion | Rs4.28 Billion | — |